| Literature DB >> 25651321 |
Geraldo Bezerra da Silva Junior1, Elizabeth De Francesco Daher2, Roberto da Justa Pires Neto3, Eanes Delgado Barros Pereira2, Gdayllon Cavalcante Meneses4, Sônia Maria Holanda Almeida Araújo1, Elvino José Guardão Barros5.
Abstract
Leprosy is a chronic disease caused by Mycobacterium leprae, highly incapacitating, and with systemic involvement in some cases. Renal involvement has been reported in all forms of the disease, and it is more frequent in multibacillary forms. The clinical presentation is variable and is determined by the host immunologic system reaction to the bacilli. During the course of the disease there are the so called reactional states, in which the immune system reacts against the bacilli, exacerbating the clinical manifestations. Different renal lesions have been described in leprosy, including acute and chronic glomerulonephritis, interstitial nephritis, secondary amyloidosis and pyelonephritis. The exact mechanism that leads to glomerulonephritis in leprosy is not completely understood. Leprosy treatment includes rifampicin, dapsone and clofazimine. Prednisone and non-steroidal anti-inflammatory drugs may be used to control acute immunological episodes.Entities:
Mesh:
Year: 2015 PMID: 25651321 PMCID: PMC4325518 DOI: 10.1590/S0036-46652015000100002
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846